心筋虚血の世界市場レポート 2024年

心筋虚血市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR7.0％で10億4,000万米ドルに成長します。予測期間の成長は、様々な心臓関連疾患の流行、心血管疾患に対する人々の意識の高まり、ライフスタイルの進化、糖尿病患者の増加、ヘルスケア支出の増加などに起因しています。この期間に予想される主な動向には、心筋虚血に対する先進治療の採用、ヘルスケアインフラの改善、治療オプションの進歩、デジタルヘルスソリューションの統合、心臓リハビリテーションプログラムの導入などがあります。

糖尿病の有病率の増加が心筋虚血市場の成長を促進すると予想されます。糖尿病は、血糖値を調整するのに重要なインスリンを体がうまく使用できないことを特徴とする代謝障害の一群で構成されます。糖尿病の罹患率上昇の要因としては、肥満、座りがちなライフスタイル、遺伝的素因などが挙げられます。このような糖尿病有病率の増加は、心筋虚血の増加とも相関しており、この疾患の診断、治療、管理ソリューションに対する需要の高まりを促しています。例えば、国際糖尿病連合は2021年に、世界の20～79歳の成人の約5億3,700万人が糖尿病に罹患していると報告しており、この数は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。このように、糖尿病の罹患率の増加は、心筋虚血市場の拡大の触媒として機能しています。

心筋虚血市場の主な企業は、炎症に対処して冠動脈疾患患者の心血管リスクを軽減するLodoco（コルヒチン）などの革新的な医薬品の開発に注力しています。Lodocoは、動脈硬化性疾患または複数の心血管危険因子が確立している成人の心筋梗塞（MI）、脳卒中、冠動脈血行再建術、および心血管死亡のリスクを低下させることを特に適応としています。例えば、米国の製薬会社Agepha Pharma社は、米国食品医薬品局（FDA）の承認を受け、2023年6月にLodoco（コルヒチン）を発売しました。この承認は、心血管系の炎症をターゲットとした初のFDA承認治療薬として、重要なマイルストーンとなった。LoDoCo2を含む臨床試験では、コルヒチン0.5mgを1日1回投与することで、プラセボと比較して心血管イベントの相対リスクが31％低下することが実証されました。ロドコは、対象となる患者の重篤な心血管イベントのリスクを軽減するために処方されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の心筋虚血市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の心筋虚血市場の実績：規模と成長, 2018-2023
• 世界の心筋虚血市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

• 世界の心筋虚血市場：タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 症状有
• 無症状
• 世界の心筋虚血市場：治療と診断別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 診断
• 治療
• 世界の心筋虚血市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 病院と診療所
• 診断センター
• 外来手術センター

第7章 地域別・国別分析

• 世界の心筋虚血市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界の心筋虚血市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心筋虚血市場：競合情勢
• 心筋虚血市場：企業プロファイル
  • Cardinal Health Inc.
  • Pfizer Inc.
  • Roche Holding AG
  • Bayer AG
  • Sanofi SA

第31章 その他の大手企業と革新的企業

• Novartis AG
• Bristol-Myers Squibb Company
• AstraZeneca Plc
• Abbott Laboratories Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• Medtronic Plc
• Boehringer Ingelheim International GmbH
• Gilead Sciences Inc.
• Siemens Healthineers AG
• Merck KGaA
• GE HealthCare Technologies Inc.
• Fujifilm Holdings Corporation
• Baxter International Inc.
• Regeneron Pharmaceuticals Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Myocardial ischemia, also known as cardiac ischemia, occurs when there is reduced blood flow to the heart muscle, resulting in insufficient oxygen and nutrient delivery. This condition can lead to potential damage to the heart muscle. The primary cause of myocardial ischemia is the narrowing of coronary arteries due to the buildup of plaque, which limits blood flow.

There are two main types of myocardial ischemia, symptomatic and asymptomatic. Symptomatic myocardial ischemia refers to cases where individuals experience symptoms such as chest pain or discomfort (angina) during episodes of reduced blood flow to the heart muscle. Various treatments and diagnostic approaches are utilized by different end-users including hospitals, clinics, diagnostic centers, and ambulatory surgery centers.

The myocardial ischemia market research report is one of a series of new reports from The Business Research Company that provides myocardial ischemia market statistics, including myocardial ischemia industry global market size, regional shares, competitors with a myocardial ischemia market share, detailed myocardial ischemia market segments, market trends, and opportunities, and any further data you may need to thrive in the myocardial ischemia industry. This myocardial ischemia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The myocardial ischemia market size has grown strongly in recent years. It will grow from $0.74 billion in 2023 to $0.79 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the utilization of telemedicine and remote monitoring, the development of novel reperfusion therapies for myocardial infarction (MI), increased cases of obesity, higher prevalence of high blood pressure, and an increase in the incidence of heart attacks.

The myocardial ischemia market size is expected to see strong growth in the next few years. It will grow to $1.04 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the prevalence of various heart-related diseases, increasing awareness among the population about cardiovascular diseases, evolving lifestyles, rising cases of diabetes, and higher healthcare expenditures. Major trends anticipated during this period include the adoption of advanced treatments for myocardial ischemia, improvements in healthcare infrastructure, advancements in treatment options, integration of digital health solutions, and the introduction of cardiac rehabilitation programs.

The increasing prevalence of diabetes is expected to drive growth in the myocardial ischemia market. Diabetes comprises a group of metabolic disorders characterized by the body's ineffective use of insulin, crucial for regulating blood sugar levels. Factors contributing to the rising incidence of diabetes include obesity, sedentary lifestyles, and genetic predisposition. This higher prevalence of diabetes correlates with increased occurrences of myocardial ischemia, prompting greater demand for diagnostic, therapeutic, and management solutions for this condition. For instance, the International Diabetes Federation reported in 2021 that approximately 537 million adults aged 20-79 worldwide had diabetes, a number projected to increase to 643 million by 2030 and 783 million by 2045. Thus, the rising incidence of diabetes serves as a catalyst for the myocardial ischemia market's expansion.

Key players in the myocardial ischemia market are focusing on developing innovative medications such as Lodoco (colchicine) to address inflammation and reduce cardiovascular risk in patients with coronary artery disease. Lodoco is specifically indicated to lower the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adults with established atherosclerotic disease or multiple cardiovascular risk factors. For example, Agepha Pharma, a US-based pharmaceutical firm, launched Lodoco (colchicine) in June 2023, following approval by the US Food and Drug Administration (FDA). This approval marked a significant milestone as the first FDA-approved treatment targeting cardiovascular inflammation. Clinical trials, including LoDoCo2, demonstrated a 31% relative risk reduction in cardiovascular events with colchicine 0.5 mg once daily compared to placebo. Lodoco is prescribed to mitigate the risk of serious cardiovascular events in eligible patients.

In December 2021, Pfizer, a prominent US-based pharmaceutical company, acquired Arena Pharmaceuticals for $6.7 billion, expanding its portfolio and capabilities in inflammation and immunology. This acquisition strengthens Pfizer's position in developing breakthrough treatments for immuno-inflammatory diseases, including myocardial ischemia. Arena Pharmaceuticals, a US biopharmaceutical firm, offers therapeutic solutions for myocardial ischemia.

Major companies operating in the myocardial ischemia market are Cardinal Health Inc., Pfizer Inc., Roche Holding AG, Bayer AG, Sanofi SA, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories Inc., Eli Lilly and Company, Novo Nordisk A/S, Medtronic Plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Siemens Healthineers AG, Merck KGaA, GE HealthCare Technologies Inc., Fujifilm Holdings Corporation, Baxter International Inc., Regeneron Pharmaceuticals Inc., Boston Scientific Corporation, Daiichi Sankyo Company Limited, Canon Medical Systems Corporation

North America was the largest region in the myocardial ischemia market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the myocardial ischemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the myocardial ischemia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myocardial ischemia market consists of sales of statin, anticoagulants, and antiplatelet agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myocardial Ischemia Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myocardial ischemia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for myocardial ischemia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The myocardial ischemia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Symptomatic; Asymptomatic
• 2) By Treatment And Diagnosis: Diagnosis; Treatment
• 3) By End User: Hospitals And Clinics; Diagnostic Centers; Ambulatory Surgery Centers
• Companies Mentioned: Cardinal Health Inc.; Pfizer Inc.; Roche Holding AG; Bayer AG; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Myocardial Ischemia Market Characteristics

3. Myocardial Ischemia Market Trends And Strategies

4. Myocardial Ischemia Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Myocardial Ischemia Market Size and Growth

• 5.1. Global Myocardial Ischemia Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Myocardial Ischemia Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Myocardial Ischemia Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Myocardial Ischemia Market Segmentation

• 6.1. Global Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Symptomatic
• Asymptomatic
• 6.2. Global Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Diagnosis
• Treatment
• 6.3. Global Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Diagnostic Centers
• Ambulatory Surgery Centers

7. Myocardial Ischemia Market Regional And Country Analysis

• 7.1. Global Myocardial Ischemia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Myocardial Ischemia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Myocardial Ischemia Market

• 8.1. Asia-Pacific Myocardial Ischemia Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Myocardial Ischemia Market

• 9.1. China Myocardial Ischemia Market Overview
• 9.2. China Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Myocardial Ischemia Market

• 10.1. India Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Myocardial Ischemia Market

• 11.1. Japan Myocardial Ischemia Market Overview
• 11.2. Japan Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Myocardial Ischemia Market

• 12.1. Australia Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Myocardial Ischemia Market

• 13.1. Indonesia Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Myocardial Ischemia Market

• 14.1. South Korea Myocardial Ischemia Market Overview
• 14.2. South Korea Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Myocardial Ischemia Market

• 15.1. Western Europe Myocardial Ischemia Market Overview
• 15.2. Western Europe Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Myocardial Ischemia Market

• 16.1. UK Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Myocardial Ischemia Market

• 17.1. Germany Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Myocardial Ischemia Market

• 18.1. France Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Myocardial Ischemia Market

• 19.1. Italy Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Myocardial Ischemia Market

• 20.1. Spain Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Myocardial Ischemia Market

• 21.1. Eastern Europe Myocardial Ischemia Market Overview
• 21.2. Eastern Europe Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Myocardial Ischemia Market

• 22.1. Russia Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Myocardial Ischemia Market

• 23.1. North America Myocardial Ischemia Market Overview
• 23.2. North America Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Myocardial Ischemia Market

• 24.1. USA Myocardial Ischemia Market Overview
• 24.2. USA Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Myocardial Ischemia Market

• 25.1. Canada Myocardial Ischemia Market Overview
• 25.2. Canada Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Myocardial Ischemia Market

• 26.1. South America Myocardial Ischemia Market Overview
• 26.2. South America Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Myocardial Ischemia Market

• 27.1. Brazil Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Myocardial Ischemia Market

• 28.1. Middle East Myocardial Ischemia Market Overview
• 28.2. Middle East Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Myocardial Ischemia Market

• 29.1. Africa Myocardial Ischemia Market Overview
• 29.2. Africa Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Myocardial Ischemia Market Competitive Landscape And Company Profiles

• 30.1. Myocardial Ischemia Market Competitive Landscape
• 30.2. Myocardial Ischemia Market Company Profiles
  • 30.2.1. Cardinal Health Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Pfizer Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Roche Holding AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Sanofi SA
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Myocardial Ischemia Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca Plc
• 31.4. Abbott Laboratories Inc.
• 31.5. Eli Lilly and Company
• 31.6. Novo Nordisk A/S
• 31.7. Medtronic Plc
• 31.8. Boehringer Ingelheim International GmbH
• 31.9. Gilead Sciences Inc.
• 31.10. Siemens Healthineers AG
• 31.11. Merck KGaA
• 31.12. GE HealthCare Technologies Inc.
• 31.13. Fujifilm Holdings Corporation
• 31.14. Baxter International Inc.
• 31.15. Regeneron Pharmaceuticals Inc.

32. Global Myocardial Ischemia Market Competitive Benchmarking

33. Global Myocardial Ischemia Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Myocardial Ischemia Market

35. Myocardial Ischemia Market Future Outlook and Potential Analysis

• 35.1 Myocardial Ischemia Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Myocardial Ischemia Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Myocardial Ischemia Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer